Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
96.95
-1.25 (-1.27%)
At close: Jan 30, 2026, 4:00 PM EST
97.90
+0.95 (0.98%)
After-hours: Jan 30, 2026, 7:56 PM EST
Revolution Medicines Analyst Ratings
Total Analysts
16
Consensus Rating
Strong Buy
Price Target
$100.13
Upside
+3.28%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $75 → $150 | Buy | Maintains | $75 → $150 | +54.72% | Jan 27, 2026 |
| Stifel | Stifel | Strong Buy Maintains $85 → $170 | Strong Buy | Maintains | $85 → $170 | +75.35% | Jan 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $77 → $140 | Buy | Maintains | $77 → $140 | +44.40% | Jan 21, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $92 → $160 | Strong Buy | Maintains | $92 → $160 | +65.03% | Jan 20, 2026 |
| Mizuho | Mizuho | Buy Maintains $90 → $143 | Buy | Maintains | $90 → $143 | +47.50% | Jan 13, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $75 | Buy | Initiates | $75 | -22.64% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $71 → $82 | Buy | Maintains | $71 → $82 | -15.42% | Nov 6, 2025 |
| Wedbush | Wedbush | Buy Maintains $77 → $80 | Buy | Maintains | $77 → $80 | -17.48% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $66 → $72 | Strong Buy | Maintains | $66 → $72 | -25.73% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $73 | Strong Buy | Maintains | $72 → $73 | -24.70% | Nov 6, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $77 | Buy | Initiates | $77 | -20.58% | Nov 3, 2025 |
| Mizuho | Mizuho | Buy Initiates $90 | Buy | Initiates | $90 | -7.17% | Oct 21, 2025 |
| Raymond James | Raymond James | Strong Buy Maintains $72 → $76 | Strong Buy | Maintains | $72 → $76 | -21.61% | Oct 17, 2025 |
| Wedbush | Wedbush | Buy Reiterates $77 | Buy | Reiterates | $77 | -20.58% | Oct 17, 2025 |
| Stifel | Stifel | Strong Buy Initiates $85 | Strong Buy | Initiates | $85 | -12.33% | Oct 16, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $65 → $73 | Strong Buy | Maintains | $65 → $73 | -24.70% | Sep 12, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.